Brito-Zerón P, Baldini C, Bootsma H, Bowman SJ, Jonsson R, Mariette X, Sivils K, Theander E, Tzioufas A, Ramos-Casals M. Sjögren syndrome. Nat Reviews Disease Primers. 2016;2(1):1–20.


Google Scholar 

Seror R, Chiche L, Beydon M, Desjeux G, Zhuo J, Vannier-Moreau V, Devauchelle-Pensec V. Estimated prevalence, incidence and healthcare costs of Sjögren’s syndrome in France: a national claims-based study. RMD Open. 2024;10(1):e003591.

Nocturne G, Pontarini E, Bombardieri M, Mariette X. Lymphomas complicating primary Sjögren’s syndrome: from autoimmunity to lymphoma. Rheumatology (Oxford). 2021;60(8):3513–21.


Google Scholar 

Ansari N, Salesi M. The association between primary sjogren’s syndrome and non-Hodgkin’s lymphoma: a systematic review and meta-analysis of cohort studies. Clin Rheumatol. 2024. p. 1–10.

Ebert EC. Gastrointestinal and hepatic manifestations of Sjogren syndrome. J Clin Gastroenterol. 2012;46(1):25–30.


Google Scholar 

Andréasson K, Ohlsson B, Mandl T. Elevated levels of faecal calprotectin in primary Sjögren’s syndrome is common and associated with concomitant organic Gastrointestinal disease. Arthritis Res Therapy. 2016;18:1–6.


Google Scholar 

Wang LH, Wang WM, Lin CY, Lin SH, Shieh CC. Bidirectional relationship between primary Sjögren syndrome and Non-Hodgkin lymphoma: A nationwide Taiwanese Population-based study. J Rheumatol. 2020;47(9):1374–8.


Google Scholar 

Hemminki K, Liu X, Ji J, Sundquist J, Sundquist K. Autoimmune disease and subsequent digestive tract cancer by histology. Ann Oncol. 2012;23(4):927–33.


Google Scholar 

Kang J, Kim H, Kim J, Choi S, Jung SY, Jang EJ, Cho SK, Sung YK. Risk of malignancy in Korean patients with primary Sjögren’s syndrome. Int J Rheum Dis. 2020;23(9):1240–7.


Google Scholar 

Brito-Zerón P, Kostov B, Fraile G, Caravia-Durán D, Maure B, Rascón F-J, Zamora M, Casanovas A, Lopez-Dupla M, Ripoll M. Characterization and risk estimate of cancer in patients with primary Sjögren syndrome. J Hematol Oncol. 2017;10:1–12.


Google Scholar 

Theander E, Henriksson G, Ljungberg O, Mandl T, Manthorpe R, Jacobsson LT. Lymphoma and other malignancies in primary Sjögren’s syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis. 2006;65(6):796–803.


Google Scholar 

Zhong H, Liu S, Wang Y, Xu D, Li M, Zhao Y, Zeng X. Primary Sjögren’s syndrome is associated with increased risk of malignancies besides lymphoma: A systematic review and meta-analysis. Autoimmun Rev. 2022;21(5):103084.


Google Scholar 

Wu Y, Li Y, Giovannucci E. Potential impact of time trend of lifestyle risk factors on burden of major Gastrointestinal cancers in China. Gastroenterology. 2021;161(6):1830–41. e1838.


Google Scholar 

Landgren AM, Landgren O, Gridley G, Dores GM, Linet MS, Morton LM. Autoimmune disease and subsequent risk of developing alimentary tract cancers among 4.5 million US male veterans. Cancer. 2011;117(6):1163–71.


Google Scholar 

Castro FA, Liu X, Försti A, Ji J, Sundquist J, Sundquist K, Koshiol J, Hemminki K. Increased risk of hepatobiliary cancers after hospitalization for autoimmune disease. Clin Gastroenterol Hepatol. 2014;12(6):1038–e10451037.


Google Scholar 

Lee J, Lee JS, Park S-H, Shin SA, Kim K. Cohort profile: the National health insurance Service–National sample cohort (NHIS-NSC), South Korea. Int J Epidemiol. 2016;46(2):e15–15.


Google Scholar 

Organization WH. International statistical classification of diseases and related health problems: alphabetical index. Volume 3. WHO. 2004.

Brandt JE, Priori R, Valesini G, Fairweather D. Sex differences in Sjögren’s syndrome: a comprehensive review of immune mechanisms. Biol Sex Differ. 2015;6:19.


Google Scholar 

Mihai A, Caruntu C, Jurcut C, Blajut FC, Casian M, Opris-Belinski D, Ionescu R, Caruntu A. The spectrum of extraglandular manifestations in primary Sjögren’s syndrome. J Personalized Med. 2023;13(6):961.


Google Scholar 

Seror R, Bowman SJ, Brito-Zeron P, Theander E, Bootsma H, Tzioufas A, Gottenberg J-E, Ramos-Casals M, Dörner T, Ravaud P, et al. EULAR Sjögren’s syndrome disease activity index (ESSDAI): a user guide. RMD Open. 2015;1(1):e000022.


Google Scholar 

Lee AYS, Wang JJ, Gordon TP, Reed JH. Phases and natural history of Sjögren’s disease: A new model for an old disease? Arthritis Care Res. 2023;75(7):1580–7.


Google Scholar 

Aslan B, Öğüt TS, Erbasan F, Dilbil M, Çelik E, Terzioğlu ME, Yazısız V. The risk of cancer in patients with primary Sjögren syndrome: a single-center study from Turkey. Turk J Med Sci. 2022;52(3):587–95.


Google Scholar 

Sjöström B, Bredberg A, Mandl T, Alonso-Magdalena L, Ohlsson B, Lavasani S, Nouri M, Henriksson G. Increased intestinal permeability in primary Sjögren’s syndrome and multiple sclerosis. J Transl Autoimmun. 2021;4:100082.


Google Scholar 

Mandl T, Marsal J, Olsson P, Ohlsson B, Andréasson K. Severe intestinal dysbiosis is prevalent in primary Sjögren’s syndrome and is associated with systemic disease activity. Arthritis Res Therapy. 2017;19(1):237.


Google Scholar 

Genua F, Raghunathan V, Jenab M, Gallagher WM, Hughes DJ. The role of gut barrier dysfunction and Microbiome dysbiosis in colorectal cancer development. Front Oncol. 2021;11:626349.


Google Scholar 

Chang C-C, Chang Y-S, Wang S-H, Lin S-Y, Chen Y-H, Chen JH. Primary sjogren’s syndrome and the risk of acute pancreatitis: a nationwide cohort study. BMJ Open. 2017;7(8):e014807.


Google Scholar 

Park SM, Kim KB, Han J-H, Kim N, Kang TU, Swan H, Kim HJ. Incidence and risk of pancreatic cancer in patients with acute or chronic pancreatitis: a population-based cohort study. Sci Rep. 2023;13(1):18930.


Google Scholar 

Kirkegård J, Cronin-Fenton D, Heide-Jørgensen U, Mortensen FV. Acute pancreatitis and pancreatic cancer risk: A nationwide Matched-Cohort study in Denmark. Gastroenterology. 2018;154(6):1729–36.


Google Scholar 

Suh M, Song S, Cho HN, Park B, Jun JK, Choi E, et al. Trends in participation rates for the National cancer screening program in Korea, 2002–2012. Cancer Res Treatment: Official J Korean Cancer Association. 2017;49(3):798–806.


Google Scholar 

Brito-Zerón P, Flores-Chávez A, Horváth IF, Rasmussen A, Li X, Olsson P, Vissink A, Priori R, Armagan B, Hernandez-Molina G et al. Mortality risk factors in primary Sjögren syndrome: a real-world, retrospective, cohort study. eClinicalMedicine 2023. p. 61.

Kim HJ, Kim KH, Hann HJ, Han S, Kim Y, Lee SH, Kim DS, Ahn HS. Incidence, mortality, and causes of death in physician-diagnosed primary Sjögren’s syndrome in korea: A nationwide, population-based study. Semin Arthritis Rheum. 2017;47(2):222–7.


Google Scholar 

Maciel G, Crowson CS, Matteson EL, Cornec D. Incidence and mortality of Physician-Diagnosed primary Sjögren syndrome: time trends over a 40-Year period in a Population-Based US cohort. Mayo Clin Proc. 2017;92(5):734–43.


Google Scholar 

Weng MY, Huang YT, Liu MF, Lu TH. Incidence and mortality of treated primary sjogren’s syndrome in taiwan: a population-based study. J Rheumatol. 2011;38(4):706–8.


Google Scholar 

Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2024;74(3):229–63.


Google Scholar